Sijia Zhang Yu Xiao Leichong Chen Zhenyu Li Yan Zong Kuikui Zhu Rui Meng
10.1515/biol-2022-0062
Open Life Sci
2022 Jun 15;17(1):577-585.
anti-angiogenesis chemotherapy combination therapy immunotherapy pulmonary large-cell neuroendocrine carcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/35800072/
Case Reports
PMC9202532
35800072
Endostar plus pembrolizumab combined with a platinum-based dual chemotherapy regime for advanced pulmonary large-cell neuroendocrine carcinoma as a first-line treatment: A case report
2022